Foxp transcription factors in regulatory T cells
调节性 T 细胞中的 Foxp 转录因子
基本信息
- 批准号:10347180
- 负责人:
- 金额:--
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-01-01 至 2024-12-31
- 项目状态:已结题
- 来源:
- 关键词:AddressAdoptive TransferAutoantibodiesAutoimmuneAutoimmune DiseasesAutoimmunityCD4 Positive T LymphocytesCaringCellsCellularityDNA BindingDataDevelopmentDisease modelExhibitsExperimental Autoimmune EncephalomyelitisFOXP1 geneFOXP3 geneFamilyFamily memberGene ExpressionGene Expression RegulationGenerationsGenesGenetic TranscriptionGoalsHeart TransplantationHematopoietic SystemHeterodimerizationHigh-Throughput Nucleotide SequencingHomeostasisHomoHumanImmuneImmune ToleranceImmune responseImmunosuppressionImpairmentInfiltrationInflammatory Bowel DiseasesLeadLymphocyteLymphocyte ActivationLymphoid TissueMaintenanceMediatingModelingMolecularMouse StrainsMusMutationOrgan TransplantationPeripheralPhenotypePopulationProductionRegulationRegulatory T-LymphocyteRoleSelf ToleranceSolidSystemT-LymphocyteT-Lymphocyte SubsetsTechnologyTestingThymus GlandTransplantationValidationVeteransbaseclinically relevantdimerimprovedin vivoin vivo Modelin vivo evaluationmembernovelprematuretranscription factortranslational approachtransplant model
项目摘要
Regulatory T cells (Tregs) are critical for actively maintaining immune tolerance. The Foxp family of
transcription factors is composed of four members; Foxp1, Foxp3 and Foxp4 are expressed in lymphocytes.
Foxp family members bind DNA as homo- and hetero-dimers to regulate gene expression. Regulatory T cells
are CD4+ T cells that express Foxp3. We have generated mice in which both Foxp1 and Foxp4 are deleted in
either all T lymphocytes or in Tregs, leaving Foxp3 the only potentially expressed family member in this T cell
subset. Our preliminary data demonstrate that combined loss of Foxp1 and Foxp4 in all T lymphocytes based
on CD4 Cre-mediated deletion substantially alters the development of Tregs in the thymus, reduces peripheral
Treg cellularity, and alters suppressive function. When loss of Foxp1 and Foxp4 is limited to the Foxp3+ Treg
population, there is a dramatic phenotype characterized by lymphocyte activation/expansion, autoantibody
production, and early lethality. The overall goal of this proposal is to understand how Foxp1 and Foxp4 alter
the development, homeostasis and function of Foxp3+ Tregs. To address this question we propose to
generate and use novel mouse strains in which Foxp1 and Foxp4 are deleted at different stages of Treg
development. We will use high throughput sequencing technology to investigate gene regulation by Foxp1
and/or Foxp4. We will test Tregs deficient in Foxp1 and Foxp4 in relevant models of autoimmunity and
transplantation. Understanding these fundamental aspects of Treg generation, homeostasis and function are
critical to translational strategies of Treg augmentation being developed for use in autoimmune disease and
solid-organ transplantation.
调节性T细胞是主动维持免疫耐受的关键。FoxP家族的
转录因子由四个成员组成:Foxp1、Foxp3和Foxp4在淋巴细胞中表达。
FoxP家族成员以同源和异源二聚体的形式与DNA结合,调节基因表达。调节性T细胞
是表达Foxp3的CD4+T细胞。我们已经产生了Foxp1和Foxp4同时缺失的小鼠
所有的T淋巴细胞或在Tregs中,使Foxp3成为该T细胞中唯一可能表达的家族成员
子集。我们的初步数据显示,在所有T淋巴细胞中,Foxp1和Foxp4的联合缺失
在CD4Cre介导的缺失实质上改变胸腺中Tregs的发育,减少外周
Treg细胞密度,并改变抑制功能。当Foxp1和Foxp4的丢失仅限于Foxp3+Treg时
在人群中,有一种戏剧性的表型,其特征是淋巴细胞活化/扩增,自身抗体
生产和早期致命性。本提案的总体目标是了解Foxp1和Foxp4如何更改
Foxp3+Tregs的发育、动态平衡及其功能为了解决这个问题,我们建议
产生和使用在Treg的不同阶段缺失Foxp1和Foxp4的新小鼠品系
发展。我们将使用高通量测序技术来研究Foxp1对基因的调控
和/或Foxp4。我们将在相关的自身免疫模型中检测Foxp1和Foxp4缺陷的Tregs,并
移植。了解Treg生成、动态平衡和功能的这些基本方面
Treg增强的翻译策略被开发用于自身免疫性疾病和
实体器官移植。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
JONATHAN S MALTZMAN其他文献
JONATHAN S MALTZMAN的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('JONATHAN S MALTZMAN', 18)}}的其他基金
Foxp transcription factors in regulatory T cells
调节性 T 细胞中的 Foxp 转录因子
- 批准号:
10553154 - 财政年份:2021
- 资助金额:
-- - 项目类别:
Immune control of chronic viral infection in solid organ transplantation
实体器官移植中慢性病毒感染的免疫控制
- 批准号:
10059137 - 财政年份:2019
- 资助金额:
-- - 项目类别:
Immune control of chronic viral infection in solid organ transplantation
实体器官移植中慢性病毒感染的免疫控制
- 批准号:
10595487 - 财政年份:2019
- 资助金额:
-- - 项目类别:
Immune control of chronic viral infection in solid organ transplantation
实体器官移植中慢性病毒感染的免疫控制
- 批准号:
10295188 - 财政年份:2019
- 资助金额:
-- - 项目类别:
Foxp transcription factors in regulatory T cell development and homeostasis
Foxp 转录因子在调节性 T 细胞发育和稳态中的作用
- 批准号:
8915931 - 财政年份:2014
- 资助金额:
-- - 项目类别:
Signals Affecting Homestasis and Tolerance in Memory T Cells
影响记忆 T 细胞稳态和耐受性的信号
- 批准号:
8468635 - 财政年份:2010
- 资助金额:
-- - 项目类别:
Signals Affecting Homestasis and Tolerance in Memory T Cells
影响记忆 T 细胞稳态和耐受性的信号
- 批准号:
8264562 - 财政年份:2010
- 资助金额:
-- - 项目类别:
Signals Affecting Homestasis and Tolerance in Memory T Cells
影响记忆 T 细胞稳态和耐受性的信号
- 批准号:
8660025 - 财政年份:2010
- 资助金额:
-- - 项目类别:
Signals Affecting Homestasis and Tolerance in Memory T Cells
影响记忆 T 细胞稳态和耐受性的信号
- 批准号:
7768851 - 财政年份:2010
- 资助金额:
-- - 项目类别:
Signals Affecting Homestasis and Tolerance in Memory T Cells
影响记忆 T 细胞稳态和耐受性的信号
- 批准号:
8068688 - 财政年份:2010
- 资助金额:
-- - 项目类别:
相似海外基金
Time to ATTAC: Adoptive Transfer of T cells Against gp100+ Cells to treat LAM
ATTAC 时间:针对 gp100 细胞的 T 细胞过继转移来治疗 LAM
- 批准号:
10682121 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Phase I clinical trial of adoptive transfer of autologous folate receptor-alpha redirected CAR T cells for ovarian cancer
自体叶酸受体-α重定向CAR T细胞过继转移治疗卵巢癌的I期临床试验
- 批准号:
10576370 - 财政年份:2022
- 资助金额:
-- - 项目类别:
Phase I clinical trial of adoptive transfer of autologous folate receptor-alpha redirected CAR T cells for ovarian cancer
自体叶酸受体-α重定向CAR T细胞过继转移治疗卵巢癌的I期临床试验
- 批准号:
10387023 - 财政年份:2022
- 资助金额:
-- - 项目类别:
Determining mechanisms of enhanced antitumor efficacy of four-day expanded Th17 cells for adoptive transfer
确定用于过继转移的四天扩增 Th17 细胞增强抗肿瘤功效的机制
- 批准号:
10248409 - 财政年份:2019
- 资助金额:
-- - 项目类别:
A phase I clinical study of adoptive transfer of regulatory T cells (Tregs) and low-dose interleukin-2 (IL-2) for the treatment of chronic graft-versus-host disease (GVHD): gene-marking to inform rational combination therapy
调节性 T 细胞 (Treg) 和低剂量白细胞介素 2 (IL-2) 过继转移治疗慢性移植物抗宿主病 (GVHD) 的 I 期临床研究:基因标记为合理的联合治疗提供信息
- 批准号:
nhmrc : GNT1163111 - 财政年份:2019
- 资助金额:
-- - 项目类别:
Project Grants
Determining mechanisms of enhanced antitumor efficacy of four-day expanded Th17 cells for adoptive transfer
确定用于过继转移的四天扩增 Th17 细胞增强抗肿瘤功效的机制
- 批准号:
10462684 - 财政年份:2019
- 资助金额:
-- - 项目类别:
Gene edited lymphoid progenitors for adoptive transfer as a treatment of primary immunodeficiency
基因编辑的淋巴祖细胞用于过继转移作为原发性免疫缺陷的治疗
- 批准号:
398018062 - 财政年份:2018
- 资助金额:
-- - 项目类别:
Research Grants
Overcoming immune suppression in cancer by targeting PSGL-1 in T cells used for adoptive transfer
通过靶向用于过继转移的 T 细胞中的 PSGL-1 克服癌症中的免疫抑制
- 批准号:
9308643 - 财政年份:2017
- 资助金额:
-- - 项目类别:
Overcoming immune suppression in cancer by targeting PSGL-1 in T cells used for adoptive transfer
通过靶向用于过继转移的 T 细胞中的 PSGL-1 克服癌症中的免疫抑制
- 批准号:
9447149 - 财政年份:2017
- 资助金额:
-- - 项目类别:
Targeting Cancer miRNAs by Adoptive Transfer of Programmed B Lymphocytes
通过程序化 B 淋巴细胞的过继转移靶向癌症 miRNA
- 批准号:
8893915 - 财政年份:2014
- 资助金额:
-- - 项目类别: